Export 255 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
F. Curro, Capstraw, E., Harewood, L., Sung, A., and Network, T. P. E. A. R. L., Practice-Based Research Networks (PBRNs) Maximizing Patient Contact with Pharmacovigilance and Signaling, in Drug Information Association, 2007.
C. Cukras, Agron, E., Klein, M., ,, Chew, E., Gensler, G., Wong, W., and Group, T. Age- Relate, Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28, Ophthalmology, vol. 117, pp. 489-499, 2010.
C. Cukras, Agrón, E., Klein, M. L., Ferris, F. L., Chew, E. Y., Gensler, G., and Wong, W. T., Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28., Ophthalmology, vol. 117, no. 3, pp. 489-99, 2010.
K. Csaky, Blodi, B., Osman, M., Cousin, S., Callanan, D., and Hammel, K., The utility of dynamic indocyanine green angiography (D-ICG) in patients with neovascular age-related macular degeneration (AMD) as determined by two prospective clinical trials, 2006.
K. Csaky, Blodi, B., Osman, M., Fullmer, K., Callanan, D., and Cousins, S., Phase II Trial of Celecoxib and Photodynamic Therapy (C-PDT) for Neovascular Age-Related Macular Degeneration, in The 28th Annual Macula Society Meeting, Key Biscayne, FL, 2005.
K. Csaky and Group, C. P. D. T. 1Study Rese, Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics, 2004.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., de Souza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., O'Connell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., Mascola, J. R., Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., and Ananworanich, J., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
A. Crisan, Ghadessi, M., Buerki, C., Vergara, I. A., Thompson, D. J. S., Erho, E., Sierocinski, T., Haddad, Z., Zimmermann, B., Sosu-Sedzorme, W., Harko, S., Black, P. C., Davicioni, E., and Jenkins, R. B., Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence, in 2012 ASTRO - American Society for Radiation Oncology, Boston, MA, 2012.
P. S. Creticos, Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., and Broide, D., Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis., N Engl J Med, vol. 355, no. 14, pp. 1445-55, 2006.
B. C Creech, Dekker, C. L., Ho, D., Phillips, S., Mackey, S., Murray-Krezan, C., Pau, M. Grazia, Hendriks, J., Brown, V., Dally, L. G., Versteege, I., and Edwards, K. M., Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults., Hum Vaccin Immunother, vol. 9, no. 12, pp. 2548-57, 2013.
C. B. Creech, Dekker, C. L., Ho, D., Phillips, S., Mackey, S., Murray-Krezan, C., M Pau, G., Hendriks, J., Brown, V., Dally, L. G., Versteege, I., and Edwards, K. M., Randomized, Placebo-Controlled Trial to Assess the Safety and Immunogenicity of an Adenovirus type 35-Based Circumsporozoite Malaria Vaccine in Healthy Adults, Hum Vaccin Immunother, vol. 9, pp. 2548-2557, 2013.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 308 St, Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults, PLoS One, vol. 10, p. e0123969, 2015.
M. C. Crank, Gordon, I. J., Yamshchikov, G. V., Sitar, S., Hu, Z., Enama, M. E., Holman, L. S. A., Bailer, R. T., Pearce, M. B., Koup, R. A., Mascola, J. R., Nabel, G. J., Tumpey, T. M., Schwartz, R. M., Graham, B. S., and Ledgerwood, J. E., Phase 1 study of pandemic H1 DNA vaccine in healthy adults., PLoS One, vol. 10, no. 4, p. e0123969, 2015.
J. H. Cox, Ferrari, G., Kalams, S. A., Lopaczynski, W., Oden, N., D'souza, M. P., and Group, E. Collaborat, Results of an ELISPOT Proficiency Panel Conducted in 11 Laboratories Participating in International Human Immunodeficiency Virus Type 1 Vaccine Trials, AIDS Res Hum Retroviruses, vol. 21, pp. 68-81, 2005.
J. H. Cox, Ferrari, G., Kalams, S. A., Lopaczynski, W., Oden, N., and M D'souza, P., Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials., AIDS Res Hum Retroviruses, vol. 21, no. 1, pp. 68-81, 2005.
K. Cornetta, Laughlin, M., Carter, S., Wall, D., Weinthal, J., Delaney, C., Wagner, J., Sweetman, R., McCarthy, P., and Chao, N., Umbilical Cord Blood Transplantation in Adults: Results of the Prospective Cord Blood Transplantation (COBLT), Biol Blood Marrow Transplant, vol. 11, pp. 2149-2160, 2005.
K. Cornetta, Laughlin, M., Carter, S. L., Wall, D., Weinthal, J., Sievers, E., Wagner, J., Sweetman, R., McCarthy, P., Jensen, L., and Chao, N., Umbilical cord blood transplantation in adults: results of a prospective, multi-institutional, NHLBI sponsored trial, 2002.
K. Cornetta, Laughlin, M., Carter, S., Wall, D., Weinthal, J., Delaney, C., Wagner, J., Sweetman, R., McCarthy, P., and Chao, N., Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT)., Biol Blood Marrow Transplant, vol. 11, no. 2, pp. 149-60, 2005.
L. Corey, McElrath, M. J., Weinhold, K., Matthews, T., Stablein, D., Graham, B., Keefer, M., Schwartz, D., and Gorse, G., Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group., J Infect Dis, vol. 177, no. 2, pp. 301-9, 1998.
L. Corey, McElrath, M. J., Weinhold, K., Matthews, T., Stablein, D., Graham, B., Keefer, M., Schwartz, D., Gorse, G., and Group, theA. I. D. S. Vacci, Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen, J Infec Dis, vol. 177, pp. 301-9, 1998.
J. B. Copley, Staffeld, C., Lindberg, J., Hansen, A., Bailey, C., Anand, R., and Van Veldhuisen, P., Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts, Transplant Proc, vol. 30, pp. 1254-6, 1998.
J. B. Copley, Staffeld, C., Lindberg, J., Hansen, A., Bailey, C., Anand, R., and Van Veldhuisen, P., Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts., Transplant Proc, vol. 30, no. 4, pp. 1254-6, 1998.
J. Copley, Staffeld, C., Lindberg, J., Baily, C., and Van Veldhuisen, P., The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity, 1999.
J. Copley, Staffeld, C., Lindberg, J., Bailey, C., and Van Veldhuisen, P., Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks, 2000.
M. - A. Conteh, Goldstein, S. T., Wurie, H. R., Gidudu, J., Lisk, D. Radcliffe, Carter, R. J., Seward, J. F., Hampton, L. M., Wang, D., Andersen, L. E., Arvay, M., Schrag, S. J., Dawson, P., Fombah, A. E., Petrie, C. R., Feikin, D. R., Russell, J. B. W., Lindblad, R., Kargbo, S. A. S., Samai, M., and Mahon, B. E., Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola., J Infect Dis, vol. 217, no. suppl_1, pp. S33-S39, 2018.